Skip to main content
FinSpry Logo
FinSpry
XLO logo
XLO
(NASDAQ)
Xilio Therapeutics, Inc.
$8.51-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Xilio Therapeutics (XLO) Stock Price & Financial Analysis

Xilio Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.20 - $8.57
52-Week High$10.42
52-Week Low$0.62
Open$8.30
Volume26.00K
Average Volume (3M)26.00K
Market Cap1.23B
Shares Outstanding144.11M
Price to Sales (P/S)38.42
EV/EBITDA-26.68
Revenue (TTM)31.80M
Net Income (TTM)-58.49M
Free Cash Flow (TTM)-17.58M
EPS (TTM)$-0.41
Profit Margin-183.90%
Operating Margin-137.64%
50-Day MA$7.91
200-Day MA$3.51
52-Week Change1145.23%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Xilio Therapeutics

What is the current stock price for XLO?

As of the latest trading session, XLO stock trades at $8.51. The 52-week range is $0.62–$10.42, with a day range of $8.20–$8.57.

What is the P/E ratio for XLO?

The P/E ratio (Price-to-Earnings) for XLO is shown in the Key Statistics section. This valuation metric helps compare Xilio Therapeutics, Inc. to industry peers.

Does XLO pay dividends?

Xilio Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XLO?

Analyst ratings and recommendations for XLO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of XLO?

Xilio Therapeutics's market capitalization is $1.23B, classifying it as a small-cap company. Xilio Therapeutics operates in the Healthcare sector within the Biotechnology industry.